Ken Griffin (Citadel Advisors) exit Madrigal Pharmaceuticals, Inc.
Ken Griffin (Citadel Advisors) exit $-107.2M of disclosed value in Madrigal Pharmaceuticals, Inc..
Signal
Investor Move
Action
Exit
Capital
$-107.2M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.